Ohtuvayre™is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients First inhaled COPD treatment providing bronchodilation and non-steroidal anti-inflammatory effects SHANGHAI, Feb. 7, 2025 /PRNewswire/ -- Today, Nuance Pharma ("Nuance") announced that the Pharmaceutical Administration Bureau Macau approved Ohtuvayre™ (ensifentrine) for the maintenance treatment...
NEW YORK, Feb. 7, 2025 /PRNewswire/ -- Aquaron Acquisition Corp. (NASDAQ: AQU, the "Company"), a special purpose acquisition company, announced today that HUTURE Ltd....
- DoxAI to establish regional headquarters in Dubai, leveraging AI-driven automation and insights to streamline business operations - Move supports the UAE's...
TAIPEI, Feb. 7, 2025 /PRNewswire/ -- The Taiwan External Trade Development Council (TAITRA) will present Taipei AMPA and E-Mobility Taiwan under the new "360°...